Five other patients with variants in TP53 (n = 3), NF1 (n = 2), RUNX1 (n = 1), and NRAS (n = 1) received a graft from an unrelated donor, while one patient with AML and a debut age at 46 years, with a RUNX1‐variant was transplanted with a related donor. This evidence concerns the gene NF1 and acute myeloid leukemia.